Optical Fiber Bull Stock Clarification: The Company Has No Business Relationship with NVIDIA! | After-Hours Announcement Highlights

Optical fiber stock urgently clarifies no connection with NVIDIA! Stock with five limit-up days in seven trading sessions issues risk warning; pharmaceutical giant announces its holding subsidiary has signed an exclusive option agreement.

Golden10 DataMay 13 21:02

No business relationship with NVIDIA whatsoever! A 33 billion yuan fiber-optic concept stock releases clarification announcement | Post-market announcements summary

China Jushi: Plans to invest 4.431 billion yuan in building a production line project for 50,000 tons of electronic yarn and 320 million meters of electronic cloth annually

cls.cnMay 13 20:42

Two controlling persons of the CRO giant are under investigation by the CSRC! | Selected After-Hours Announcements

Two controlling shareholders of a CRO giant have been investigated by the CSRC! A well-known liquor company announced that its actual controller has changed to the Municipal Finance Bureau; a wind power giant urgently clarified that its shareholder is not a popular male star...

Golden10 DataMay 12 21:06

Suspected of violations and illegal activities related to information disclosure on shareholding changes! The actual controller of a 40 billion CRO leading company has been investigated by the CSRC | Post-market announcement highlights

Vanke A: Shenzhen Metro Group provides the company with a RMB 2.5 billion shareholder loan facility, and the company signs a supplementary agreement for the RMB 22 billion shareholder loan.

cls.cnMay 12 20:51

Low stock prices prompt shareholders to urge share repurchases; Kanghong Pharmaceutical plans to invest over 1 billion yuan annually in R&D in the future | Earnings meeting coverage

①During the earnings call, several participants expressed dissatisfaction with the current stock price of Kanghong Pharmaceutical and suggested that the company take various measures to boost investor confidence; ②Kanghong Pharmaceutical also shared updates on the progress of its highly anticipated R&D pipeline.

cls.cnMay 11 20:04

“Good News” Turns into “Thunderclap”? Key Pipeline Fails to Meet Primary Endpoint Significance; Leading Pharmaceutical Firm with 50 Billion Market Cap Plummets to Trading Halt

①This morning, Sinopharm Aucta's stock opened and immediately plunged to the daily limit down, likely due to the clinical progress announcement of its core product released last night; ②In the announcement, the company attempted to convey “positive signals” to the public through secondary endpoints such as KCCQ scores. However, the failure of core indicators to achieve statistical significance has become the Sword of Damocles hanging over the valuation expectations of this key product.

cls.cnMay 11 17:55